HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin⁻Pyrazine Derivatives Based on Partial Least Squares Discriminant Analysis.

Abstract
Hederagenin (He) is a novel triterpene template for the development of new antitumor compounds. In this study, 26 new He⁻pyrazine derivatives were synthetized in an attempt to develop potent antitumor agents; they were screened for in vitro cytotoxicity against tumor and non-tumor cell lines. The majority of these derivatives showed much stronger cytotoxic activity than He. Remarkably, the most potent was compound 9 (half maximal inhibitory concentration (IC50) was 3.45 ± 0.59 μM), which exhibited similar antitumor activities against A549 (human non-small-cell lung cancer) as the positive drug cisplatin (DDP; IC50 was 3.85 ± 0.63 μM), while it showed lower cytotoxicity on H9c2 (murine heart myoblast; IC50 was 16.69 ± 0.12 μM) cell lines. Compound 9 could induce the early apoptosis and evoke cell-cycle arrest at the synthesis (S) phase of A549 cells. Impressively, we innovatively introduced the method of cluster analysis modeled as partial least squares discriminant analysis (PLS-DA) into the structure⁻activity relationship (SAR) evaluation, and SAR confirmed that pyrazine had a profound effect on the antitumor activity of He. The present studies highlight the importance of pyrazine derivatives of He in the discovery and development of novel antitumor agents.
AuthorsKang Fang, Xiao-Hua Zhang, Yao-Tian Han, Gao-Rong Wu, De-Sheng Cai, Nan-Nan Xue, Wen-Bo Guo, Yu-Qin Yang, Meng Chen, Xin-Yu Zhang, Hui Wang, Tao Ma, Peng-Long Wang, Hai-Min Lei
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 19 Issue 10 (Sep 30 2018) ISSN: 1422-0067 [Electronic] Switzerland
PMID30274380 (Publication Type: Journal Article)
Chemical References
  • Pyrazines
  • Oleanolic Acid
  • hederagenin
Topics
  • Apoptosis (drug effects)
  • Cell Cycle (drug effects)
  • Cell Death
  • Cell Line, Tumor
  • Cell Shape (drug effects)
  • Cluster Analysis
  • Discriminant Analysis
  • Drug Design
  • Humans
  • Inhibitory Concentration 50
  • Least-Squares Analysis
  • Oleanolic Acid (analogs & derivatives, chemical synthesis, chemistry, toxicity)
  • Principal Component Analysis
  • Pyrazines (chemical synthesis, chemistry, toxicity)
  • Staining and Labeling
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: